| Name | [(2R,3R,4R,5R)-3,4-diacetyloxy-5-(2,6-dichloropurin-9-yl)oxolan-2-yl]methyl acetate |
|---|---|
| Synonyms |
[4-acetyloxy-5-(acetyloxymethyl)-2-(2,6-dichloropurin-9-yl)oxolan-3-yl] ethanoate
9H-Purine, 2,6-dichloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl) 9-[2,3,5-TRI-O-ACETYL-SS-D-RIBOFURANOSYL]-2,6-DICHLOROPURINE 2,6-Dichloro-9-(2',3',5'-tri-O-acetyl-b-D-ribofuranosyl)purine [3,4-BIS(ACETYLOXY)-5-(2,6-DICHLOROPURIN-9-YL)OXOLAN-2-YL]METHYL ACETATE 2,6-DCl-2′,3′,5′,-TAc-PuR 2,6-Dichloro-9-(2′,3′,5′-tri-O-acetyl-β-D-ribofuranosyl)purine 9-[2,3,5-tri-O-acetyl-D-ribofuranosyl]-2,6-dichloropurine [3,4-Bis(acetyloxy)-5-(2,6-dichloro-9H-purin-9-yl)oxolan-2-yl]methyl acetate BINO-004 2,6-Dichloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-9H-purine 2R,3R,4R,5R)-4-(acetyloxy)-2-[(acetyloxy)methyl]-5-(2,6-dichloro-9H-purin-9-yl)tetrahydro-3-furanyl acetate 2,6-dichloro-9-(2,3,5-tri-O-acetylpentofuranosyl)-9H-purine (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2,6-dichloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate [4-acetyloxy-5-(acetyloxymethyl)-2-(2,6-dichloropurin-9-yl)oxolan-3-yl] acetate 9H-Purine,2,6-dichloro-9-(2,3,5-tri-O-acetyl-b-D-ribofuranosyl) Regadenoson Impurity 42 2,6-DICHLORO-9-(2,3,5-TRI-O-ACETYL-B-D-RIBOFURANOSYL)-9H-PURINE acetic acid [4-acetoxy-5-(acetoxymethyl)-2-(2,6-dichloropurin-9-yl)tetrahydrofuran-3-yl] ester 2,6-Dichloro-2',3',5'-triacetyl-purineriboside 2',3',5'-Tri-O-Acetyl-2,6-Dichloropurine [3,4-diacetyloxy-5-(2,6-dichloropurin-9-yl)oxolan-2-yl]methyl acetate 2-Chloroadenosine impurity B 2,6-Dichloro-9-(2’,3’,5’-tri-O-acetyl-β-D-ribofuranosyl)purine 2,6-Dichloro-2',3',5'-triacetyl-purine riboside |
| Description | 2,6-Dichloro-2',3',5'-triacetyl-purine riboside is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.69g/cm3 |
|---|---|
| Boiling Point | 555.3ºC at 760mmHg |
| Molecular Formula | C16H16Cl2N4O7 |
| Molecular Weight | 447.2 |
| Flash Point | 289.6ºC |
| Exact Mass | 446.0396043 |
| PSA | 131.73000 |
| LogP | 1.45700 |
| Index of Refraction | 1.671 |
| Hazard Codes | Xn |
|---|---|
| HS Code | 2934999090 |
|
~86%
3056-18-6 |
| Literature: Francom, Paula; Robins, Morris J. Journal of Organic Chemistry, 2003 , vol. 68, # 2 p. 666 - 669 |
|
~84%
3056-18-6 |
| Literature: Qu, Guirong; Liu, Qibin Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2005 , vol. 44, # 1 p. 196 - 197 |
|
~75%
3056-18-6 |
| Literature: Robins; Uznanski Canadian Journal of Chemistry, 1981 , vol. 59, # 17 p. 2601 - 2607 |
|
~%
3056-18-6 |
| Literature: Journal of Labelled Compounds and Radiopharmaceuticals, , vol. 40, p. 85 - 87 |
|
~%
3056-18-6 |
| Literature: Journal of Labelled Compounds and Radiopharmaceuticals, , vol. 40, p. 85 - 87 |
|
~70%
3056-18-6 |
| Literature: Journal of Organic Chemistry, , vol. 68, # 2 p. 666 - 669 |
|
~%
3056-18-6 |
| Literature: Canadian Journal of Chemistry, , vol. 59, # 17 p. 2601 - 2607 |
|
~%
3056-18-6 |
| Literature: Canadian Journal of Chemistry, , vol. 59, # 17 p. 2601 - 2607 |
|
~%
3056-18-6 |
| Literature: Canadian Journal of Chemistry, , vol. 59, # 17 p. 2601 - 2607 |
| Precursor 9 | |
|---|---|
| DownStream 5 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |